Metformin can improve insulin sensitivity in non-diabetic individuals with conditions like prediabetes or metabolic syndrome, potentially delaying the onset of diabetes.

Metformin has shown efficacy in reducing insulin resistance in non-diabetic people, particularly those with prediabetes, helping prevent the progression to type 2 diabetes.

In non-diabetic individuals, particularly those with prediabetes or metabolic syndrome, metformin helps enhance insulin sensitivity and lower glucose production, reducing diabetes risk.

Metformin is beneficial for non-diabetic individuals with insulin resistance, such as those with prediabetes, by improving glycemic control and decreasing the risk of developing diabetes.